Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on T-Cell Adult Acute Lymphocytic Leukemia. Data from NIH RePORTER, last 36 months.
T-Cell Adult Acute Lymphocytic Leukemia has active NIH research funding with 19 funded grants totaling $14.7M.
1 new grant started in the last 12 months.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for T-Cell Adult Acute Lymphocytic Leukemia. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
2 funded grants in Translational / Drug Development but only 2 related publications found for T-cell adult acute lymphocytic leukemia. This may indicate early-stage research that hasn't yet produced published results.
3 funded grants in Gene Therapy / Cell Therapy but only 2 related publications found for T-cell adult acute lymphocytic leukemia. This may indicate early-stage research that hasn't yet produced published results.
7 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for T-cell adult acute lymphocytic leukemia. Existing research activity suggests this may be a viable area for grant applications.